These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety of clonidine and nortriptyline. Chapman NA J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142-3. PubMed ID: 8138513 [No Abstract] [Full Text] [Related]
3. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. Spencer T; Biederman J; Wilens T; Steingard R; Geist D J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873 [TBL] [Abstract][Full Text] [Related]
4. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. Prince JB; Wilens TE; Biederman J; Spencer TJ; Millstein R; Polisner DA; Bostic JQ J Child Adolesc Psychopharmacol; 2000; 10(3):193-204. PubMed ID: 11052409 [TBL] [Abstract][Full Text] [Related]
5. Nortriptyline in the treatment of ADHD: a chart review of 58 cases. Wilens TE; Biederman J; Geist DE; Steingard R; Spencer T J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):343-9. PubMed ID: 8444763 [TBL] [Abstract][Full Text] [Related]
6. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. Wilens TE; Biederman J; Mick E; Spencer TJ J Nerv Ment Dis; 1995 Jan; 183(1):48-50. PubMed ID: 7807071 [No Abstract] [Full Text] [Related]
7. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. Wilens TE; Biederman J; Spencer T; Geist DE J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754 [TBL] [Abstract][Full Text] [Related]
8. [Use of drugs in attention deficit hyperactivity disorders]. Guardiola A; Terra AR; Pereira KR; Rotta NT Arq Neuropsiquiatr; 1997 Sep; 55(3B):594-7. PubMed ID: 9629412 [TBL] [Abstract][Full Text] [Related]
9. Case 6: a free solution. Shader RI; Oesterheld JR J Clin Psychopharmacol; 1995 Aug; 15(4):297. PubMed ID: 7593722 [No Abstract] [Full Text] [Related]
10. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders]. Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180 [TBL] [Abstract][Full Text] [Related]
11. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. Wilens TE; Biederman J; Spencer TJ J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):45-8. PubMed ID: 9000780 [TBL] [Abstract][Full Text] [Related]
12. Does minimal brain dysfunction persist into adulthood? Collis P S Afr Med J; 1978 Apr; 53(13):477. PubMed ID: 675391 [No Abstract] [Full Text] [Related]
13. Tricyclic medication in children and the QT interval: case report and discussion. Alderton HR Can J Psychiatry; 1995 Aug; 40(6):325-9. PubMed ID: 7585402 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents. Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for megavitamin therapy in the treatment of attention deficit hyperactivity disorder? Haslam RH Adv Neurol; 1992; 58():303-10. PubMed ID: 1414636 [No Abstract] [Full Text] [Related]
17. Usefulness of methylphenidate. Haddock ST N Engl J Med; 1972 Feb; 286(7):375. PubMed ID: 5008562 [No Abstract] [Full Text] [Related]